Nirma to buy majority stake in Glenmark Life Sciences
Glenmark Prescription drugs will promote 75% stake in its subsidiary Glenmark Life Sciences to Nirma Restricted, for Rs 5652 crore, ...
Tag: Nirma
Nirma closes in on Glenmark’s API arm, emerges sole contender as bid deadline ends
Mumbai: The Nirma Group is the frontrunner to accumulate Glenmark Life Sciences (GLS), an 82.84% subsidiary of Glenmark Prescribed drugs. ...